drugset / Trial / NCT03292302
Phase 1 Study of ELX-02 in Healthy Adults
Phase 1
Completed
18 enrolled
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 1 Single Ascending Dose Study in Normal Healthy Volunteers
Timeline
- Start
- 2017-09-26
- Primary completion
- 2017-12-15
- Completion
- 2017-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ELX-02 | Small molecule | — | — |